Patient Education as TopicSocieties, MedicalNew ZealandPubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMe...
Patient satisfaction was very favorable in both enhanced conditions; however, those treated in the the Nutrition Center Model were more satisfied (P<.05) with program components.Conclusions: The impact of nutrition ...
No studies have shown statin cholesterol-lowering drugs to be effective for women at any age, nor for men 69 years of age or older, who do not already have heart disease or diabetes. Better than 50 adults have to take a cholesterol-lowering drug for 1 patient to avoid a mortal heart at...
Booklet: Cholesterol Counts: Steps for lowering your patient's blood cholesterol, National Cholesterol Education Program, National Heart, Lung, and Blood Institute, 1985. From the National Cholesterol Education Program, Box C-C3, National Heart, Lung, and Blood Institute, Bldg. 31, Rm. 4A21, Be...
Ezetimibe monotherapy for cholesterol lowering in 2722 people: Systematic review and meta-analysis of randomized controlled trials. J. Intern. Med. 2009, 265, 568–580. [Google Scholar] [CrossRef] Hammersley, D.; Signy, M. Ezetimibe: An update on its clinical usefulness in specific patient ...
The algorithm ensures a personalized approach to LLT, considering the patient’s prior treatment history and the individualized goal for LDL-C reduction. Abbreviations: ACS, acute coronary syndrome; LDL-C, low-density lipoprotein cholesterol; N = not; PCSK9i, proprotein convertase subtilisin/kexin ...
low density lipoprotein cholesterol male patient peripheral occlusive artery disease pharmacology physiology population pravastatin prescription prevention risk risk factor rosuvastatin simvastatin smoking society statin therapy triacylglycerol Register to see more suggestions Mendeley helps you to ...
doi:10.1016/B978-141600203-1.50120-7W. SodemanInstructions for Geriatric Patients (Third Edition)
Schettler, G., " The role of diet and drugs in lowering serum cholesterol in the postmyocardial infarction patient, " Cardiovasc. Drugs, Ther., 1989, 2/6 (795-799).Schettler, G., The role of diet and drugs in lowering serum cholesterol in the postmyocardial infarction patient, Cardiovasc...
The present invention relates to pharmaceutical formulations comprising a betablocker and a cholesterol-lowering agent in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier, as well as a kit of parts, a method for treatment and use of the formulations for the prophylactic or ...